BioNews
CVS (chorionic villus sampling)
CVS (chorionic villus sampling) is a test carried usually carried out between the 11th and 14th week of pregnancy, in which a few cells of the placenta are removed for biochemical or genetic testing. This is most commonly to check a fetus for conditions such as Down’s syndrome and other chromosomal or genetic disorders.
US Court awards further $100 million over prenatal test patents
A Texas court has awarded $100 million more damages to a company whose patents for non-invasive prenatal testing technology were infringed by a competitor...
Same-day karyotyping test unveiled
A new rapid test can detect missing or extra chromosomes as part of prenatal and fertility care...
FDA recommends additional confirmatory testing alongside NIPT
Prenatal genetic test results need to be communicated better, according to the US Food and Drug Administration...
Webinar Review: Neonatal testing for rare diseases – The power of knowing
A single blood drop, taken without your consent, can be life-changing...
Illumina and Roche settle and dismiss patent lawsuits over 'Harmony' tests
A long-running court case over non-invasive prenatal testing patents has been settled...
Informed consent to non-invasive prenatal testing: findings from a qualitative study in Lebanon and in Quebec
Non-invasive prenatal testing (NIPT) was first introduced in 2011, when breakthroughs in sequencing technology allowed the analysis of cell-free fetal DNA(cffDNA) in maternal blood to detect genetic abnormalities in the foetus, such as trisomy 21 (Down
Event Review: Jewish Genetics Awareness Month — Knowledge is power
Jnetics and Chana shared their first joint event, with leading experts speaking about Jewish genetic disorder carrier screening, fertility advice and the reproductive options available to ensure genetic disorders are not passed onto future children...
Illumina wins NIPT patent case in UK High Court
The UK Patents Court has ruled that two separate non-invasive prenatal tests infringe patents licensed by the US firm Illumina...
Radio Review: One to One - Jane Hill meets Caroline Harding
The first of two episodes of the One-to-One programme about people from families affected by genetic diseases: exploring the emotional impact of a family member's diagnosis and how relatives decide whether or not to find out if the condition will also aff